Astrazeneca PLC - stock earnings
AZN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 960.0 million USD | 12.0 billion USD |
| 2023Q3 | 1.4 billion USD | 11.5 billion USD |
| 2023Q2 | 1.8 billion USD | 11.4 billion USD |
| 2023Q1 | 1.8 billion USD | 10.9 billion USD |
| 2022Q4 | 901.0 million USD | 11.2 billion USD |
| 2022Q3 | 1.6 billion USD | 11.0 billion USD |
| 2022Q2 | 360.0 million USD | 10.8 billion USD |
| 2022Q1 | 386.0 million USD | 11.4 billion USD |
| 2021Q4 | -347.0 million USD | 12.0 billion USD |
| 2021Q3 | -1.7 billion USD | 9.9 billion USD |
| 2021Q2 | 550.0 million USD | 8.2 billion USD |
| 2021Q1 | 1.6 billion USD | 7.3 billion USD |
| 2020Q4 | 1.0 billion USD | 7.4 billion USD |
| 2020Q3 | 648.0 million USD | 6.6 billion USD |
| 2020Q2 | 756.0 million USD | 6.3 billion USD |
| 2020Q1 | 780.0 million USD | 6.4 billion USD |
| 2019Q4 | 313.0 million USD | 6.7 billion USD |
| 2019Q3 | 299.0 million USD | 6.4 billion USD |
| 2019Q2 | 130.0 million USD | 5.8 billion USD |
| 2019Q1 | 593.0 million USD | 5.5 billion USD |
| 2018Q4 | 1.0 billion USD | 6.4 billion USD |
| 2018Q3 | 431.0 million USD | 5.3 billion USD |
| 2018Q2 | 350.0 million USD | 5.2 billion USD |
| 2018Q1 | 340.0 million USD | 5.2 billion USD |
| 2017Q4 | 1.3 billion USD | 5.8 billion USD |
| 2017Q3 | 686.0 million USD | 6.2 billion USD |
| 2017Q2 | 477.0 million USD | 5.1 billion USD |
| 2017Q1 | 537.0 million USD | 5.4 billion USD |
| 2016Q4 | 1.8 billion USD | 5.6 billion USD |
| 2016Q3 | 1.0 billion USD | 5.7 billion USD |
| 2016Q2 | -3.0 million USD | 5.6 billion USD |
| 2016Q1 | 646.0 million USD | 6.1 billion USD |
| 2015Q4 | 808.0 million USD | 6.4 billion USD |
| 2015Q3 | 770.0 million USD | 5.9 billion USD |
| 2015Q2 | 697.0 million USD | 6.3 billion USD |
| 2015Q1 | 550.0 million USD | 6.1 billion USD |
| 2014Q4 | -321.0 million USD | 6.7 billion USD |
| 2014Q3 | 254.0 million USD | 6.5 billion USD |
| 2014Q2 | 796.0 million USD | 6.5 billion USD |
| 2014Q1 | 504.0 million USD | 6.4 billion USD |
| 2013Q4 | -524.0 million USD | 6.8 billion USD |
| 2013Q3 | 1.2 billion USD | 6.3 billion USD |
| 2013Q2 | 823.0 million USD | 6.2 billion USD |
| 2013Q1 | 1.0 billion USD | 6.4 billion USD |
| 2012Q4 | 1.5 billion USD | 7.3 billion USD |
| 2012Q3 | 1.5 billion USD | 6.7 billion USD |
| 2012Q2 | 1.6 billion USD | 6.7 billion USD |
| 2012Q1 | 1.6 billion USD | 7.3 billion USD |
| 2011Q4 | 1.5 billion USD | 8.7 billion USD |
| 2011Q3 | 3.5 billion USD | 8.2 billion USD |
| 2011Q2 | 2.1 billion USD | 8.4 billion USD |
| 2011Q1 | 1.6 billion USD | 8.6 billion USD |
| 2010Q4 | 1.6 billion USD | 8.6 billion USD |
| 2010Q3 | 1.5 billion USD | 7.9 billion USD |
| 2010Q2 | 2.1 billion USD | 8.2 billion USD |
| 2010Q1 | 2.8 billion USD | 8.6 billion USD |
| 2009Q4 | 1.6 billion USD | 8.9 billion USD |
| 2009Q3 | 2.1 billion USD | 8.2 billion USD |
| 2009Q2 | 1.7 billion USD | 8.0 billion USD |
| 2009Q1 | 2.1 billion USD | 7.7 billion USD |
| 2008Q4 | 1.2 billion USD | 8.2 billion USD |
| 2008Q3 | 1.7 billion USD | 7.8 billion USD |
| 2008Q2 | 1.6 billion USD | 8.0 billion USD |
| 2008Q1 | 1.5 billion USD | 7.7 billion USD |
| 2007Q4 | 1.3 billion USD | 8.2 billion USD |
| 2007Q3 | 1.3 billion USD | 7.2 billion USD |
| 2007Q2 | 1.4 billion USD | 7.3 billion USD |
| 2007Q1 | 1.6 billion USD | 7.0 billion USD |
| 2006Q4 | 1.4 billion USD | 7.2 billion USD |
| 2006Q3 | 1.6 billion USD | 6.5 billion USD |
| 2006Q2 | 1.6 billion USD | 6.6 billion USD |
| 2006Q1 | 1.4 billion USD | 6.2 billion USD |
| 2005Q4 | 1.2 billion USD | 6.3 billion USD |
| 2005Q3 | 1.2 billion USD | 5.8 billion USD |
| 2005Q2 | 1.2 billion USD | 6.1 billion USD |
| 2005Q1 | 1.0 billion USD | 5.7 billion USD |
| 2004Q4 | 1.1 billion USD | 5.8 billion USD |
| 2004Q3 | 1.1 billion USD | 5.3 billion USD |
| 2004Q2 | 811.0 million USD | 5.3 billion USD |
| 2004Q1 | 797.0 million USD | 5.1 billion USD |
| 2003Q4 | 635.0 million USD | 4.9 billion USD |
| 2003Q3 | 798.5 million USD | 4.8 billion USD |
| 2003Q2 | 668.9 million USD | 4.5 billion USD |
| 2003Q1 | 933.5 million USD | 4.7 billion USD |
| 2002Q4 | 433.3 million USD | 4.7 billion USD |
| 2002Q3 | 659.8 million USD | 4.3 billion USD |
| 2002Q2 | 775.0 million USD | 4.3 billion USD |
| 2002Q1 | 959.5 million USD | 4.4 billion USD |
| 2001Q4 | 2.0 billion USD | 11.5 billion USD |
| 2001Q3 | 711.0 million USD | 4.0 billion USD |
| 2001Q2 | 686.0 million USD | 4.1 billion USD |
| 2001Q1 | 780.5 million USD | 4.0 billion USD |
| 2000Q4 | 549.3 million USD | 6.5 billion USD |
| 2000Q3 | 651.2 million USD | 3.8 billion USD |
| 2000Q2 | 679.0 million USD | 4.0 billion USD |
| 2000Q1 | 661.1 million USD | 3.9 billion USD |
| 1999Q4 | -173.6 million USD | 5.1 billion USD |
| 1999Q3 | 484.0 million USD | 4.3 billion USD |
| 1999Q2 | 416.0 million USD | 4.5 billion USD |
| 1999Q1 | 416.0 million USD | 4.5 billion USD |
| 1998Q4 | 205.0 million USD | 1.9 billion USD |
| 1998Q3 | 233.4 million USD | 2.3 billion USD |
| 1998Q2 | 366.0 million USD | 2.4 billion USD |
| 1998Q1 | 366.0 million USD | 2.4 billion USD |
| 1997Q4 | 321.6 million USD | 2.3 billion USD |
| 1997Q3 | 295.1 million USD | 2.1 billion USD |
| 1997Q2 | 372.5 million USD | 2.3 billion USD |
| 1997Q1 | 372.5 million USD | 2.3 billion USD |
| 1996Q4 | 630.0 million USD | 4.6 billion USD |
| 1996Q3 | 235.6 million USD | 2.3 billion USD |
| 1996Q2 | 315.0 million USD | 2.3 billion USD |
| 1996Q1 | 315.0 million USD | 2.3 billion USD |
| 1995Q4 | 121.0 million USD | 1.8 billion USD |
| 1995Q3 | 132.7 million USD | 1.9 billion USD |
| 1995Q2 | 269.5 million USD | 2.0 billion USD |
| 1995Q1 | 269.4 million USD | 2.0 billion USD |
| 1994Q4 | 327.1 million USD | 1.8 billion USD |
| 1994Q3 | 173.3 million USD | 1.8 billion USD |
| 1994Q2 | 348.1 million USD | 1.8 billion USD |
| 1994Q1 | 193.7 million USD | 1.8 billion USD |
| 1993Q4 | 122.5 million USD | 1.5 billion USD |
| 1993Q3 | 136.0 million USD | 1.5 billion USD |
| 1993Q2 | 189.5 million USD | 1.7 billion USD |
| 1993Q1 | 189.5 million USD | 1.7 billion USD |
AZN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 6.0 billion USD | 45.8 billion USD |
| 2022 | 3.3 billion USD | 44.4 billion USD |
| 2021 | 112.0 million USD | 37.4 billion USD |
| 2020 | 3.2 billion USD | 26.6 billion USD |
| 2019 | 1.3 billion USD | 24.4 billion USD |
| 2018 | 2.2 billion USD | 22.1 billion USD |
| 2017 | 3.0 billion USD | 22.5 billion USD |
| 2016 | 3.5 billion USD | 23.0 billion USD |
| 2015 | 2.8 billion USD | 24.7 billion USD |
| 2014 | 1.2 billion USD | 26.1 billion USD |
| 2013 | 2.6 billion USD | 25.7 billion USD |
| 2012 | 6.3 billion USD | 28.0 billion USD |
| 2011 | 10.0 billion USD | 33.6 billion USD |
| 2010 | 8.1 billion USD | 33.3 billion USD |
| 2009 | 7.5 billion USD | 32.8 billion USD |
| 2008 | 6.1 billion USD | 31.6 billion USD |
| 2007 | 5.6 billion USD | 29.6 billion USD |
| 2006 | 6.0 billion USD | 26.5 billion USD |
| 2005 | 4.7 billion USD | 24.0 billion USD |
| 2004 | 3.7 billion USD | 21.4 billion USD |
| 2003 | 3.0 billion USD | 18.8 billion USD |
| 2002 | 2.8 billion USD | 17.8 billion USD |
| 2001 | 4.2 billion USD | 23.6 billion USD |
| 2000 | 2.5 billion USD | 18.1 billion USD |
| 1999 | 1.1 billion USD | 18.4 billion USD |
| 1998 | 1.2 billion USD | 9.1 billion USD |
| 1997 | 1.2 billion USD | 8.6 billion USD |
| 1996 | 1.1 billion USD | 9.2 billion USD |
| 1995 | 519.2 million USD | 7.6 billion USD |
| 1994 | 692.6 million USD | 7.0 billion USD |
| 1993 | 637.5 million USD | 6.6 billion USD |
| 1992 | 121.3 million USD | 6.0 billion USD |
| 1991 | 645.6 million USD | 7.4 billion USD |
| 1990 | 428.2 million USD | 7.3 billion USD |
AZN
Price: $75.17
52 week price:
Dividend Yield: 0.04%
5-year range yield:
Forward Dividend Yield: 2.62%
Payout Ratio: 104.23%
Payout Ratio Range:
Dividend Per Share: 1.97 USD
Earnings Per Share: 1.90 USD
P/E Ratio: 35.25
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 4.8 million
Ebitda: 1.8 billionMarket Capitalization: 207.1 billion
Average Dividend Frequency: 2
Years Paying Dividends: 32
DGR3: 1.18%
DGR5: 1.14%
DGR10: 8.24%
DGR20: 11.80%